Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Gynecology

Free Subscription 10.06.2024 2 Acta Obstet Gynecol Scand 3 Am J Obstet Gynecol 3 Anticancer Res 1 Aust N Z J Obstet Gynaecol 3 BMC Cancer 3 BMJ 1 Cancer 2 Clin Cancer Res 8 Eur J Obstet Gynecol Reprod Biol 4 Fertil Steril 4 Gynecol Endocrinol 12 Gynecol Oncol 4 Hum Reprod 5 Int J Gynaecol Obstet 1 JAMA 3 Obstet Gynecol 4 PLoS One 2 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. GUDNADOTTIR U, Kamau N, Fornes R, Nguyen MH, et al
   Antibiotic or gastric acid inhibitor use during pregnancy and postpartum depression: Population-based cohort study.
   Acta Obstet Gynecol Scand. 2024 Jun 3. doi: 10.1111/aogs.14864.
   PubMed         Abstract available
   
   
2. TAKANO M, Tachihara M, Kamiya M, Kotaki H, et al
   Intertwin discordance of aldosterone levels in amniotic fluid with placental anastomoses in monochorionic twins: Insight into the pathophysiology of twin-to-twin transfusion syndrome.
   Acta Obstet Gynecol Scand. 2024 May 31. doi: 10.1111/aogs.14859.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

3. BLACHUT B, Woodard TJ, Morris D, Vanderlan JR, et al
   Inequities in health insurance influence psychosocial outcomes and coping among patients seeking gynecologic oncology care.
   Am J Obstet Gynecol. 2024;230:e6-e11.
   PubMed        
   
   
4. DEVORE GR, Polanco B, Lee W, Fowlkes JB, et al
   Maternal rest improves growth in small-for-gestational-age fetuses (<10th percentile).
   Am J Obstet Gynecol. 2024 May 17:S0002-9378(24)00530.
   PubMed         Abstract available
   
   
5. ESPINOZA J, Calsavara VF, Kilpatrick S, Rana S, et al
   Plasma sFlt-1/PlGF ratio of 11.5 multiples of median predicts preeclampsia with severe features within two weeks of testing.
   Am J Obstet Gynecol. 2024 May 31:S0002-9378(24)00659.
   PubMed         Abstract available
   
   

   
   Anticancer Res

6. KITSOS-KALYVIANAKIS K, Pitsikakis K, Mamalis ME, Kalampokis E, et al
   Continuity Unveiled: Evaluating Cytoreduction Outcomes for Advanced Ovarian Cancer Amidst the COVID-19 Era at an ESGO Designated Centre of Excellence.
   Anticancer Res. 2024;44:2645-2652.
   PubMed         Abstract available
   
   
7. MORGENSTERN B, Thangarajah F, Schmidt M, Lenz C, et al
   Clinical Impact of Pelvic Sentinel Lymph Node Biopsy for Vulvar Squamous Cell Carcinoma.
   Anticancer Res. 2024;44:2621-2626.
   PubMed         Abstract available
   
   
8. LEONHARDI J, Horn LC, Aktas B, Denecke T, et al
   MRI Texture Analysis of Inguinal Lymph Node Metastasis in Vulvar Cancer - Associations With Histopathology.
   Anticancer Res. 2024;44:2709-2716.
   PubMed         Abstract available
   
   

   
   Aust N Z J Obstet Gynaecol

9. BERMAN YE, Newnham JP, Ward SV, Brown K, et al
   Ascertainment of Aboriginal and Torres Strait Islander status for assessment of perinatal health outcomes: Reported versus derived maternal ethnicity in Western Australian pregnancy data.
   Aust N Z J Obstet Gynaecol. 2024 Jun 4. doi: 10.1111/ajo.13832.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. LI J, Yang Z, Wang T, Li M, et al
    Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study.
    BMC Cancer. 2024;24:667.
    PubMed         Abstract available
    
    
11. FEREDE YA, Tassew WC, Zeleke AM
    Precancerous cervical lesion and associated factors among HIV-infected women in Ethiopia: systematic review and meta- analysis.
    BMC Cancer. 2024;24:678.
    PubMed         Abstract available
    
    
12. ALI B, Galbarczyk A, Jasienska G, Ba-Break M, et al
    Factors related to knowledge, attitudes, and behaviors regarding cervical cancer among Yemeni women.
    BMC Cancer. 2024;24:695.
    PubMed         Abstract available
    
    

    
    BMJ

13. TANNE JH
    US Republicans block bill that would have guaranteed access to contraception.
    BMJ. 2024;385:q1251.
    PubMed        
    
    
14. KITCHEN K
    Moves to limit prison custody for pregnant and postnatal women are welcome-and long overdue.
    BMJ. 2024;385:q1209.
    PubMed        
    
    
15. TANNE JH
    Texas court rejects legal challenge by women denied abortions for dangerous pregnancies.
    BMJ. 2024;385:q1216.
    PubMed        
    
    

    
    Cancer

16. BLANC-DURAND F, Camilleri GM, Bayle A, Aldea M, et al
    Clinical utility of comprehensive liquid molecular profiling in patients with advanced endometrial cancer.
    Cancer. 2024 Jun 2. doi: 10.1002/cncr.35381.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

17. LEE HHY, Chow KL, Wong HS, Chong TY, et al
    Inhibition of aberrantly overexpressed Polo-like kinase 4 is a potential effective treatment for DNA damage repair-deficient uterine leiomyosarcoma.
    Clin Cancer Res. 2024 Jun 7. doi: 10.1158/1078-0432.CCR-23-3720.
    PubMed         Abstract available
    
    
18. SANER FAM, Takahashi K, Budden T, Pandey A, et al
    Concurrent RB1 Loss and BRCA-Deficiency Predicts Enhanced Immunological Response and Long-Term Survival in Tubo-Ovarian High-Grade Serous Carcinoma.
    Clin Cancer Res. 2024 Jun 5. doi: 10.1158/1078-0432.CCR-23-3552.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

19. CHEN PF, Liang YL, Chuang YJ, Wu MH, et al
    Autologous PRP therapy for thin endometrium: A self-controlled case series study across menstrual cycles.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:12-17.
    PubMed         Abstract available
    
    
20. ENZELSBERGER SH, Oppelt P, Enengl S, Palme IS, et al
    Perioperative complications in women undergoing thermal balloon endometrial ablation after one or more cesarean deliveries.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:18-21.
    PubMed         Abstract available
    
    
21. VARVAROUSI G, Barba C, Protopapas A, Pavlidis M, et al
    Agenesis of inferior vena cava in pregnancy: A case report and narrative review.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:22-25.
    PubMed         Abstract available
    
    
22. AKAZAWA M, Hashimoto K
    Prediction of hemorrhage in placenta previa: Radiomics analysis of pelvic MRI images.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:37-42.
    PubMed         Abstract available
    
    
23. GARCIA JC, Maraver FM, Rodriguez Jimenez I, Rios-Pena L, et al
    Female sexual function in long-term cervical cancer survivors compared with healthy women and women affected by benign gynecological disorders.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:43-53.
    PubMed         Abstract available
    
    
24. LEBEAU J, Leung J, Bernard L, Zeng X, et al
    Phlegmasia cerulea dolens - A rare presentation of ovarian malignancy.
    Eur J Obstet Gynecol Reprod Biol. 2024 May 25:S0301-2115(24)00259.
    PubMed        
    
    
25. SONAGLIONI A, Pusca I, Casieri F, Dell'Anna R, et al
    Echocardiographic assessment of left atrial mechanics in women with hypertensive disorders of pregnancy: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:62-70.
    PubMed         Abstract available
    
    
26. LI F, Qi JJ, Li LX, Yan TF, et al
    Impact of insulin resistance on IVF/ICSI outcomes in women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:54-61.
    PubMed         Abstract available
    
    

    
    Fertil Steril

27. BEAN E, Knez J, Thanatsis N, De Braud L, et al
    Obstetric outcomes in women with pelvic endometriosis: A prospective cohort study.
    Fertil Steril. 2024 Jun 3:S0015-0282(24)00511.
    PubMed         Abstract available
    
    
28. BAK MJ, Farje D, Tsui EL, Lautz TB, et al
    Ovarian tissue cryopreservation in pediatric patients with malignancy involving the ovary.
    Fertil Steril. 2024 Jun 3:S0015-0282(24)00510.
    PubMed        
    
    
29. GOMPEL A, Thomas H, Plu-Bureau G, Alifano M, et al
    Outcomes of thoracic endometriosis in pregnant women.
    Fertil Steril. 2024 Jun 1:S0015-0282(24)00518.
    PubMed        
    
    
30. DUNLOP CE, Anderson RA
    Clinical Dilemmas in Ovarian Tissue Cryopreservation.
    Fertil Steril. 2024 May 31:S0015-0282(24)00516.
    PubMed         Abstract available
    
    

    
    Gynecol Endocrinol

31. 
    Statement of Retraction: Clomiphene citrate combined with metformin versus letrozole for induction of ovulation in clomiphene-resistant polycystic ovary syndrome: a randomized clinical trial.
    Gynecol Endocrinol. 2024;40:2349424.
    PubMed        
    
    
32. STUTE P, Henneicke-von Zepelin HH, Nicken P
    Transfer of preclinical study data on the influence of cimicifuga racemosaon functional changes in the hippocampus during menopause.
    Gynecol Endocrinol. 2024;40:2360066.
    PubMed         Abstract available
    
    
33. LI L, Kou Z, Zhao F, Wang Y, et al
    Network meta-analysis of four common immunomodulatory therapies for the treatment of patients with thin endometrium.
    Gynecol Endocrinol. 2024;40:2360072.
    PubMed         Abstract available
    
    
34. SHI D, Du J, Kang H, Feng L, et al
    The effect of subclinical hypothyroidism on hormonal and metabolic profiles and ovarian morphology in patients with polycystic ovary syndrome: a cross-sectional study.
    Gynecol Endocrinol. 2024;40:2358219.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

35. PITIYARACHCHI O, Ansell PJ, Coleman RL, Dinh MH, et al
    Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.
    Gynecol Oncol. 2024;187:221-226.
    PubMed         Abstract available
    
    
36. LOF P, van Soolingen NJ, Piek JMJ, Aarts JWM, et al
    Preferences and considerations for interval cytoreductive surgery in advanced ovarian cancer: The patient's perspective.
    Gynecol Oncol. 2024;187:227-234.
    PubMed         Abstract available
    
    
37. FRANCO S, Godley LA
    Myeloid neoplasms in individuals with breast and ovarian cancer and the association with deleterious germline variants.
    Gynecol Oncol. 2024;187:235-240.
    PubMed         Abstract available
    
    
38. BERTON D, Pautier P, Lorusso D, Gennigens C, et al
    Antitumor activity and safety of the PD-1 inhibitor retifanlimab in patients with recurrent microsatellite instability-high or deficient mismatch repair endometrial cancer: Final safety and efficacy results from cohort H of the POD1UM-101 phase I stud
    Gynecol Oncol. 2024;186:191-198.
    PubMed         Abstract available
    
    
39. O'CONNOR RM, Huang DS, Rimel BJ, Kim KH, et al
    Unmet financial needs among patients crowdfunding to support gynecologic cancer care.
    Gynecol Oncol. 2024;186:199-203.
    PubMed         Abstract available
    
    
40. VALABREGA G, Pothuri B, Oaknin A, Graybill WS, et al
    Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
    Gynecol Oncol. 2024;187:128-138.
    PubMed         Abstract available
    
    
41. AISAGBONHI O, Ghlichloo I, Hong DS, Roma A, et al
    Comprehensive next-generation sequencing identifies novel putative pathogenic or likely pathogenic germline variants in patients with concurrent tubo-ovarian and endometrial serous and endometrioid carcinomas or precursors.
    Gynecol Oncol. 2024;187:241-248.
    PubMed         Abstract available
    
    
42. MAKKER V, Perez-Fidalgo JA, Valabrega G, Hamilton E, et al
    Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study.
    Gynecol Oncol. 2024 Jun 3:S0090-8258(24)00234.
    PubMed         Abstract available
    
    
43. CHAN JK, Tewari K, Monk BJ, Herzog TJ, et al
    Biomarker guidance in selection among breakthrough treatment options in advanced and recurrent endometrial cancer.
    Gynecol Oncol. 2024;187:249-252.
    PubMed        
    
    
44. 
    Introduction to SGO VSI.
    Gynecol Oncol. 2024;183:A7.
    PubMed        
    
    
45. BORHO L, Bao R, Elishaev E, Dinkins KD, et al
    Association of allostatic load with overall survival in epithelial ovarian cancer.
    Gynecol Oncol. 2024;186:204-210.
    PubMed         Abstract available
    
    
46. RIEDINGER CJ, Barrington DA, Nagel CI, Khadraoui WK, et al
    Retraction notice to "Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer" [Gynecologic Oncology 183 (2024) 78-84].
    Gynecol Oncol. 2024;183:R1.
    PubMed        
    
    

    
    Hum Reprod

47. LEE S, Tejesvi MV, Hurskainen E, Aasmets O, et al
    Gut bacteriome and mood disorders in women with PCOS.
    Hum Reprod. 2024;39:1291-1302.
    PubMed         Abstract available
    
    
48. KAMPHUIS D, van Eekelen R, van Welie N, Dreyer K, et al
    Hysterosalpingo-foam sonography versus hysterosalpingography during fertility work-up: an economic evaluation alongside a randomized controlled trial.
    Hum Reprod. 2024;39:1222-1230.
    PubMed         Abstract available
    
    
49. VATIER C, Christin-Maitre S
    Epigenetic/circadian clocks and PCOS.
    Hum Reprod. 2024;39:1167-1175.
    PubMed         Abstract available
    
    
50. BURKS HR, Peck JD, Gavrizi S, Anderson ZS, et al
    Effect of prematurely elevated late follicular progesterone on pregnancy outcomes following ovarian stimulation-intrauterine insemination for unexplained infertility: secondary analysis of the AMIGOS trial.
    Hum Reprod. 2024 May 31:deae113. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

51. MAO K, Jiang P, Cai W, Lin Y, et al
    Association of gestational hepatitis B virus infection and antiviral therapy with pregnancy outcomes: A retrospective study.
    Int J Gynaecol Obstet. 2024 Jun 4. doi: 10.1002/ijgo.15716.
    PubMed         Abstract available
    
    
52. RATHCKE SL, Sinding MM, Christensen TT, Uldbjerg N, et al
    Prediction of large-for-gestational-age at birth using fetal biometry in type 1 and type 2 diabetes: A retrospective cohort study.
    Int J Gynaecol Obstet. 2024 Jun 4. doi: 10.1002/ijgo.15711.
    PubMed         Abstract available
    
    
53. WU Q, Xi F, Luo P, Dong T, et al
    Development and validation of a nomogram for predicting placenta accreta spectrum in pregnancies with one previous cesarean delivery.
    Int J Gynaecol Obstet. 2024 Jun 4. doi: 10.1002/ijgo.15702.
    PubMed         Abstract available
    
    
54. HAN X, Zheng J, Zhang L, Zhao Z, et al
    Endometrial microbial dysbiosis and metabolic alteration promote the development of endometrial cancer.
    Int J Gynaecol Obstet. 2024 Jun 4. doi: 10.1002/ijgo.15718.
    PubMed         Abstract available
    
    
55. OZCAN HC, Barut MB, Sucu S, Bademkiran MH, et al
    Is temporary clamping of the bilateral common iliac artery beneficial in reducing intraoperative blood loss in patients with segmental resected anterior placenta percreta?: A prospective observational study.
    Int J Gynaecol Obstet. 2024 Jun 6. doi: 10.1002/ijgo.15720.
    PubMed         Abstract available
    
    

    
    JAMA

56. HARRIS E
    Receiving Abortion Medication Through Mail Was Safe, Effective.
    JAMA. 2024 Jun 7. doi: 10.1001/jama.2024.10330.
    PubMed        
    
    

    
    Obstet Gynecol

57. IGLESIA CB, Choi JE, Tadir Y
    Lasers in Gynecology.
    Obstet Gynecol. 2024 Jun 6. doi: 10.1097/AOG.0000000000005635.
    PubMed         Abstract available
    
    
58. DENOBLE AE, Vazquez-Benitez G, Sheth SS, Ackerman-Banks CM, et al
    Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink.
    Obstet Gynecol. 2024 Jun 6. doi: 10.1097/AOG.0000000000005632.
    PubMed         Abstract available
    
    
59. LEVIN G, Wright JD, Burke YZ, Hamilton KM, et al
    Utilization and Surgical Outcomes of Sentinel Lymph Node Biopsy for Endometrial Intraepithelial Neoplasia.
    Obstet Gynecol. 2024 Jun 6. doi: 10.1097/AOG.0000000000005637.
    PubMed         Abstract available
    
    

    
    PLoS One

60. PENG L, Luo X, Cao B, Wang X, et al
    Exploring the link: Systemic immune-inflammation index as a marker in endometriosis-Insights from the NHANES 2001-2006 cross-sectional study.
    PLoS One. 2024;19:e0304591.
    PubMed         Abstract available
    
    
61. ACHILLES SL, Kelly CW, Hoesley CJ, Blithe DL, et al
    Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings.
    PLoS One. 2024;19:e0304552.
    PubMed         Abstract available
    
    
62. KIM NK, Suh DH, Kim K, No JH, et al
    High-throughput viable circulating tumor cell isolation using tapered-slit membrane filter-based chipsets in the differential diagnosis of ovarian tumors.
    PLoS One. 2024;19:e0304704.
    PubMed         Abstract available
    
    
63. VALDES-DEVESA V, Sanz-Rosa D, Thuissard-Vasallo IJ, Andreu-Vazquez C, et al
    Xenoestrogen concentration in women with endometriosis or leiomyomas: A case-control study.
    PLoS One. 2024;19:e0304766.
    PubMed         Abstract available
    
    

    
    Radiology

64. LONG L, Liu M, Deng X, Jin J, et al
    Tumor Stiffness Measurement at Multifrequency MR Elastography to Predict Lymphovascular Space Invasion in Endometrial Cancer.
    Radiology. 2024;311:e232242.
    PubMed         Abstract available
    
    
65. EHMAN RL
    Research Reveals a Potential Role for MR Elastography in Preoperative Evaluation of Endometrial Cancer.
    Radiology. 2024;311:e241034.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.